The Pharmaceuticals Export Promotion Council of India (Pharmexcil) with the support of the High Commission of India to Ghana and the Ministry of Commerce & Industry, Government of India has organized a pharma conference dubbed “India-Ghana Pharma Business Meet” on 27th February 2023 in Accra. The conference which took place at the Marriot Hotel brought together Regulatory & Health officials, pharmaceutical industry CEOs of Ghana and India, advocacy groups in the pharma sector as well as financial institutions. The forum was immediately followed by Business-to-business meetings.
The Business Delegation led by Pharmexcil from India comprises of 45 pharmaceutical manufacturing companies. The purpose of the gathering was to promote bilateral trade between Ghana and India in pharmaceutical formulations, active ingredients, drug intermediates, biologics, surgicals, nutraceuticals and dietary supplements. “India-Ghana Pharma Business Meet” aimed at connecting the pharma companies from India to potential business partners in Ghana. The discussions were deliberate on regulatory requirements as well as market/procurement opportunities.
Addressing the delegation, the president of the Pharmaceutical Society of Ghana commended India for their investments in the pharma sector and their important roles within the Ghanaian pharmaceutical space. According to the president, “Indian generic companies have remained very important in the Ghanaian pharmaceutical markets. From all indications, Indian companies will continue to play a very active role in Ghana, particularly in light of the anticipated growth of the sector. Over the years quality improvements from Indian Pharma companies have given the confidence to use Indian products across all levels of care. World Health Organisation’s pre-qualification, cGMP and various ISO certifications of Indian companies are a testimony to it. I want to commend you all for these investments into the pharma sector”
The president called on the Indian companies to consider technology transfer agreements with local manufacturing companies as well as contract manufacturing and other joint ventures. He further called for support in developing human resource capacity in pharmaceutical production.